Amgen's CFO Peacock passes the feather to Kelly
This article was originally published in Scrip
Amgen's chief financial officer and executive vice-president Jonathon M Peacock has stepped down to "pursue broader career opportunities," handing over to Michael Kelly who will be acting CFO as of 10 January. Mr Peacock will still be employed at Amgen until May 2014 to assist with the transition. Mr Kelly is an Amgen veteran having joined the company in 2003. He most recently served as CFO for international commercial operations.